Sonnet Biotherapeutics Stock Forward View

Sonnet Biotherapeutics Additional Predictive Modules

Most predictive techniques to examine Sonnet price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sonnet using various technical indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Sonnet Biotherapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Sonnet Biotherapeutics Holdings value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Sonnet Biotherapeutics Naive Prediction Price Forecast For the 1st of February

Given 90 days horizon, the Naive Prediction forecasted value of Sonnet Biotherapeutics Holdings on the next trading day is expected to be 0.89 with a mean absolute deviation of 0.48, mean absolute percentage error of 0.35, and the sum of the absolute errors of 29.09.

Sonnet Biotherapeutics Stock Forecast Pattern

Backtest Sonnet Biotherapeutics

Sonnet Biotherapeutics Price Prediction

Buy or Sell Advice

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sonnet Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sonnet Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Sonnet Biotherapeutics Holdings. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Sonnet Biotherapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Sonnet Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sonnet Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.05 0.95 19.27 Details

Intrinsic Valuation Low Real High 0.06 1.20 19.52 Details

Bollinger Band Projection (param) Low Middle High 2.06 4.25 6.43 Details

Sonnet Biotherapeutics After-Hype Price Density Analysis

Sonnet Biotherapeutics Estimiated After-Hype Price Volatility

Sonnet Biotherapeutics Stock Price Outlook Analysis

Notes

Sonnet Biotherapeutics Hype Timeline

Sonnet Biotherapeutics is at this time traded for 1.26. The entity has historical hype elasticity of -1.8, and average elasticity to hype of competition of -1.21. Sonnet is estimated to decline in value after the next headline, with the price expected to drop to 0.95. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -24.39%, whereas the daily expected return is at this time at -3.1%. The volatility of related hype on Sonnet Biotherapeutics is about 4709.51%, with the expected price after the next announcement by competition of 0.05. The company recorded a loss per share of 6.82. Sonnet Biotherapeutics last dividend was issued on the 2nd of April 2020. The entity had 1:8 split on the 30th of September 2024. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Sonnet Biotherapeutics Related Hype Analysis

Sonnet Biotherapeutics Related Equities

Risk & Return

Correlation

Sonnet Biotherapeutics Market Strength Events

Sonnet Biotherapeutics Risk Indicators

Story Coverage note for Sonnet Biotherapeutics

Sonnet Biotherapeutics Short Properties

Other Consideration for investing in Sonnet Stock